Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01298843 · ClinicalTrials.gov registry record · Phase 4

Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital

A Phase 4 study of Infections, sponsored by Forest Laboratories.

Completed
Registry status
Phase 4
Development phase
53
Enrollment target
15
Study locations

NCT01298843 is a Phase 4 study of Infections that has completed, run by Forest Laboratories. The registered enrollment target is 53 participants, below the 3,405-participant average among 26 other Infections trials with a reported enrollment target (98% lower). The trial reports 15 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01298843, a Phase 4 study of Infections, has completed, sponsored by Forest Laboratories.

COMPLETED
Registry status
Phase 4
Development phase
53 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to assess blood levels of Ceftaroline fosamil in children.

Conditions Studied

Infections

Interventions

  • DRUG Ceftaroline fosamil

Study Locations (15)

Ohio

  • Investigational Site - Akron
  • Investigational Site - Cleveland
  • Investigational Site - Cleveland
  • Investigational site - Toledo

California

  • Investigational Site - Orange
  • Investigational Site - San Diego

Arizona

  • Investigational Site - Phoenix

Arkansas

  • Investigational Site - Little Rock

Indiana

  • Investigational Site - Indianapolis

Kentucky

  • Investigational Site - Louisville

Louisiana

  • Investigational Site - Shreveport

Mississippi

  • Investigational Site - Jackson

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2011-04
Est. Completion 2013-02
Phase Phase 4

Sponsor

Forest Laboratories

145 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01298843

The ClinicalTrials.gov registry entry for NCT01298843 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,405-participant average among 26 other Infections trials with a reported enrollment target (98% lower). The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infections appearing as the primary indexed condition, and to 1 intervention - of which Ceftaroline fosamil is the first listed.

NCT01298843 reports 15 study locations spanning 11 distinct geographic areas - top geographies include Ohio, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT01298843 about?

NCT01298843 is a clinical study titled "Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital". The purpose of this study is to assess blood levels of Ceftaroline fosamil in children.

What is the current status of trial NCT01298843?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2011-04. Estimated completion is 2013-02.

What conditions does trial NCT01298843 study?

This clinical trial studies the following conditions: Infections.

What interventions are being tested in trial NCT01298843?

The interventions under investigation include: Ceftaroline fosamil (DRUG).

Who is sponsoring clinical trial NCT01298843?

This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01298843 being conducted?

This trial has 15 study locations across Arizona, Arkansas, California, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Infections

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.